Patents by Inventor Sharan Paul

Sharan Paul has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Staufen1 regulating agents and associated methods
    Patent number: 11946046
    Abstract: Methods of minimizing dysregulation of Staufen1-associated RNA metabolism can include introducing an amount of a Staufen1-regulating agent to a target cell sufficient to minimize the dysregulation. Therapeutic compositions for treating a neurodegenerative condition associated with Staufen1-induced dysregulation of RNA metabolism can include a therapeutically effective amount of a Staufen1-regulating agent and a pharmaceutically acceptable carrier.
    Type: Grant
    Filed: June 14, 2019
    Date of Patent: April 2, 2024
    Assignee: University of Utah Research Foundation
    Inventors: Stefan M. Pulst, Daniel R. Scoles, Sharan Paul
  • Staufen1 agents and associated methods
    Patent number: 11723912
    Abstract: Methods of minimizing dysregulation of Staufen1-associated RNA metabolism can include introducing an amount of a Staufen1-regulating agent to a target cell sufficient to minimize the dysregulation. Therapeutic compositions for treating a neurodegenerative condition associated with Staufen1-induced dysregulation of RNA metabolism can include a therapeutically effective amount of a Staufen1-regulating agent and a pharmaceutically acceptable carrier.
    Type: Grant
    Filed: December 8, 2017
    Date of Patent: August 15, 2023
    Assignee: University of Utah Research Foundation
    Inventors: Stefan M. Pulst, Daniel R. Scoles, Sharan Paul
  • STAUFEN1 REGULATING AGENTS AND ASSOCIATED METHODS
    Publication number: 20210238590
    Abstract: Methods of minimizing dysregulation of Staufen1-associated RNA metabolism can include introducing an amount of a Staufen1-regulating agent to a target cell sufficient to minimize the dysregulation. Therapeutic compositions for treating a neurodegenerative condition associated with Staufen1-induced dysregulation of RNA metabolism can include a therapeutically effective amount of a Staufen1-regulating agent and a pharmaceutically acceptable carrier.
    Type: Application
    Filed: June 14, 2019
    Publication date: August 5, 2021
    Applicant: University of Utah Research Foundation
    Inventors: Stefan M. Pulst, Daniel R. Scoles, Sharan Paul
  • STAUFEN1 AGENTS AND ASSOCIATED METHODS
    Publication number: 20200069721
    Abstract: Methods of minimizing dysregulation of Staufen1-associated RNA metabolism can include introducing an amount of a Staufen1 -regulating agent to a target cell sufficient to minimize the dysregulation. Therapeutic compositions for treating a neurodegenerative condition associated with Staufen1-induced dysregulation of RNA metabolism can include a therapeutically effective amount of a Staufen1-regulating agent and a pharmaceutically acceptable carrier.
    Type: Application
    Filed: December 8, 2017
    Publication date: March 5, 2020
    Applicant: University of Utah Research Foundation
    Inventors: Stefan M. Pulst, Daniel R. Scoles, Sharan Paul
  • Method of making induced pluripotent stem cells
    Patent number: 9920333
    Abstract: Systems, constructs, and methods for reprogramming cells are provided. In one aspect, for example, a transformation construct for generating iPS cells can include an expression vector having a plurality of reprogramming factors, each reprogramming factor being under control of a separate promoter.
    Type: Grant
    Filed: December 30, 2015
    Date of Patent: March 20, 2018
    Assignee: University of Utah Research Foundation
    Inventors: Stefan M. Pulst, Sharan Paul, Warunee Dansithong
  • GENERATION OF iPS CELLS AND ASSOCIATED METHODS
    Publication number: 20160222411
    Abstract: Systems, constructs, and methods for reprogramming cells are provided. In one aspect, for example, a transformation construct for generating iPS cells can include an expression vector having a plurality of reprogramming factors, each reprogramming factor being under control of a separate promoter.
    Type: Application
    Filed: December 30, 2015
    Publication date: August 4, 2016
    Applicant: University of Utah Research Foundation
    Inventors: Stefan M. Pulst, Sharan Paul, Warunee Dansithong
  • Constructs for making induced pluripotent stem cells
    Patent number: 9228204
    Abstract: Systems, constructs, and methods for reprogramming cells are provided. In one aspect, for example, a transformation construct for generating iPS cells can include an expression vector having a plurality of reprogramming factors, each reprogramming factor being under control of a separate promoter.
    Type: Grant
    Filed: August 23, 2013
    Date of Patent: January 5, 2016
    Assignee: University of Utah Research Foundation
    Inventors: Stefan M. Pulst, Sharan Paul, Warunee Dansithong
  • GENERATION OF iPS CELLS AND ASSOCIATED METHODS
    Publication number: 20140170752
    Abstract: Systems, constructs, and methods for reprogramming cells are provided. In one aspect, for example, a transformation construct for generating iPS cells can include an expression vector having a plurality of reprogramming factors, each reprogramming factor being under control of a separate promoter.
    Type: Application
    Filed: August 23, 2013
    Publication date: June 19, 2014
    Applicant: University of Utah Research Foundation
    Inventors: Stefan M. Pulst, Sharan Paul, Warunee Dansithong